Skip to main content
Top

Drugs

Issue 5/2022

Content (10 Articles)

Glioblastoma Leading Article

Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?

Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes

Open Access Complex Regional Pain Syndrome Review Article

From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome

Thomas J. P. Mangnus, Krishna D. Bharwani, Maaike Dirckx, Frank J. P. M. Huygen

Imipenem Review Article

Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria

George G. Zhanel, Marianna Pozdirca, Alyssa R. Golden, Courtney K. Lawrence, Sheryl Zelenitsky, Liam Berry, Frank Schweizer, Denice Bay, Heather Adam, Michael A. Zhanel, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Kurt Naber, Joseph P. Lynch III, James A. Karlowsky

Dyslipidemia Review Article

Contemporary Management of Dyslipidemia

Richard A. Ferraro, Thorsten Leucker, Seth S. Martin, Maciej Banach, Steven R. Jones, Peter P. Toth

NSCLC Adis Drug Evaluation

Aumolertinib: A Review in Non-Small Cell Lung Cancer

Matt Shirley, Susan J. Keam

Open Access Post-Exposure Prophylaxis AdisInsight Report

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Lymphoma AdisInsight Report

Sugemalimab: First Approval

Sohita Dhillon, Sean Duggan

Open Access Insomnia AdisInsight Report

Daridorexant: First Approval

Anthony Markham

Open Access Correction

Correction to: Abrocitinib: First Approval

Emma D. Deeks, Sean Duggan

Open Access Correction

Correction to: Efgartigimod: First Approval

Young-A Heo